It has been one year since Canadian Prime Minister, Justin Trudeau announced that LuminUltra would be supplying the federal government with reagent for 25 million COVID-19 clinical diagnostic tests. Having now fulfilled our commitment, we wanted to take this opportunity to reflect on the past year and what it’s meant for our LuminUltra team. When… Read More
Like many companies, when we launched our strategic plan in January, we had no idea what the year would hold. We will remember 2020 not only as a year of unprecedented challenges, but of resilience and innovation. In this post, we’ll cover some of the milestones that made this a truly monumental year for LuminUltra…. Read More
LuminUltra Technologies Ltd. is proud to announce that we’ve submitted our GeneCount® COVID-19 RT-qPCR Assay Kit to the U.S. Food and Drug Administration for Emergency Use Authorization and Health Canada for an Interim Order. With this authorization we’ll be able to provide testing facilities throughout North America with a complete, customizable clinical COVID-19 testing solution…. Read More
The GeneCount® COVID-19 RT-qPCR Assay Kit has been submitted to the U.S. FDA for Emergency Use Authorization and to Health Canada for an Interim Order.